menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Meitheal Gains Exclusive XENLETA® Commercial License

    BUSINESSWIRE

    Meitheal Pharma Licenses Biosimilars from Hong Kong`s King-Friend

    CONTRACTPHARMA

    Meitheal Acquires Contepo From Nabriva To Expand Specialty Biopharma Portfolio

    INDIANPHARMAPOST

    Meitheal Acquires CONTEPO From Nabriva Therapeutics

    BUSINESSWIRE

    Meitheal Gains Exclusive Licensing for YUSIMRY, a Humira Biosimilar

    BUSINESSWIRE

    Meitheal Pharmaceuticals Announces Recent Business Progress Reinforcing

    BUSINESSWIRE

    Meitheal Announces Expansion of Portfolio of Generic Injectable Products

    BUSINESSWIRE

    Meitheal Announces Agreement for Insulin Biosimilars in the U.S.

    BUSINESSWIRE

    Meitheal Announces Closing of Secured Credit Facility Agreement for Up to $80M

    BUSINESSWIRE

    Meitheal pays Xentria $45M for right to TNF drug in lung disease

    FIERCE BIOTECH

    Meitheal Pharma Announces Membership in Association for Accessible Medicines

    BUSINESSWIRE

    Enforcement Report - Week of September 22, 2021

    FDA

    Meitheal reports positive data from anticoagulants trial for Covid-19

    CLINICALTRIALSARENA

    Meitheal and Premier: Data from study of Anticoagulant use in COVID-19 Patients

    BUSINESSWIRE

    Enforcement Report - Week of March 3, 2021

    FDA

    Meitheal`s labeling mix-up spurs muscle relaxant recall

    FIERCEPHARMA

    Meitheal Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Cisatracurium Besylate Injection

    FDA

    Meitheal Pharma Announces Launch of Enoxaparin Sodium Injection

    BUSINESSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.